Premier Alternatives

Epitel

Salt Lake City, UT · Founded 2007 · Privately Held (backing)

Developer of a brain health monitoring device designed to detect abnormal brain activities accurately. Epitel is based in Salt Lake City, UT and was founded in 2007. Its last reported valuation was $83 million in Sep 2025. It has raised $33.9 million.

Last reported valuation
$83.0M
Oct 2026
Priced at
—
Total raised
$33.9M
Last round
—

Epitel key facts

as of Oct 2026
  • Developer of a brain health monitoring device designed to detect abnormal brain activities accurately.
  • Epitel is valued at approximately $83.0M as of Oct 2026 (last reported valuation).
  • It has raised $33.9M; the latest was Later Stage VC ($21.0M) in Sep 2025.
  • Notable investors include MedTech Innovator, National Institutes of Health, Genoa Ventures, OSF Ventures, Angel Physicians Fund — 21 tracked in total.
  • 1 investment vehicle was formed to buy Epitel shares in the last 12 months, reporting $1.2M sold to 23 investors, per SEC Form D filings.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$83.0M

Epitel's last reported valuation, Sep 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Epitel with a free account
  • ·The complete investor list: 21 names
  • ·Watch Epitel: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Epitel funding rounds

No rounds on record

No funding rounds for Epitel are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Vehicles formed to buy Epitel shares

secondary demand · SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy Epitel shares, reporting $1.2M sold to 23 investors. Most recent filing Jun 2026.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle →

Membership and data by Private Market View

Companies with the most vehicle activity →

Epitel valuation

Epitel's last reported valuation was $83 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.

Institutional holders and vehicles

In the last 12 months, 1 investment vehicle was formed to buy Epitel shares, reporting $1.2 million sold to 23 investors, per SEC Form D filings (most recent Jun 2026).

Epitel investors

21 investors are on record for Epitel, including MedTech Innovator, National Institutes of Health, Genoa Ventures and OSF Ventures.

About Epitel

Developer of a brain health monitoring device designed to detect abnormal brain activities accurately. The company's device leverages a cloud-based wearable sensor system and innovative artificial intelligence (AI) technologies to provide accessible, affordable and reliable electrographic seizure detection, enabling physicians, caregivers and patients suffering from neurological disorders to access brain health insights to improve the quality of life and care.

Sector
Healthcare
HQ
Salt Lake City, UT, United States
Founded
2007
Employees
48
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.